Recall of Surgical Dye Causing Blindness at Florida Compounding Pharmacy

Several people have filed lawsuits against Franck’s Compounding Lab, based in Ocala, alleging that they contracted severe eye infections from a contaminated surgical eye dye that was manufactured by the lab.

Franck’s issued a recall of its Brilliant Blue G surgical dye in March of 2012 after it received several reports of eye infections linked to the dye. Almost two months later, the U.S. Food and Drug Administration (FDA) announced that the lab would be recalling all of its sterile human and veterinary products after bacterial and fungal growth were discovered at the facility.

The plaintiff’s are claiming that they suffered severe and debilitating eye injuries and, in some cases, permanent blindness after the dye was used during their eye surgery procedures in November 2011. The complaints state that the pharmacy knew or should have known that the dyes were unsafe. The suits allege negligence, failure to warn, and breach of warranty.

Franck’s Compounding Lab is not under the same ownership it was when the dye was manufactured. Shortly after the recall last year, the family-owned business was sold to Wells Pharmacy Network of Wellington.

Compounding labs have been under the microscope since a deadly nationwide outbreak of fungal meningitis last year was linked to contaminated lots of injectable painkillers produced by a compounding pharmacy in Massachusetts. Hundreds were sickened and more than 30 people died in the outbreak.

If you believe you have been injured by a contaminated drug, the pharmaceutical product liability attorneys at Farah & Farah in Jacksonville would like to help you. You may be entitled to compensation for damages, medical expenses, and any additional losses. Call us at (800) 533-3555 or contact us online. We will review your case and discuss your legal options at no cost to you.

Badges